Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-beta-cyclodextrin


Autoria(s): GRILLO, Renato; MELO, Nathalie F. S. de; MORAES, Carolina Morales; LIMA, Renata de; MENEZES, Carla M. S.; FERREIRA, Elizabeth Igne; ROSA, Andre Henrique; FRACETO, Leonardo Fernandes
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

Chagas disease is a serious health problem in Latin America. Hidroxymethylnitrofurazone (NFOH) is a nitrofurazone prodrug more active than nitrofurazone against Trypanosoma cruzi. However, NFOH presents low aqueous solubility, high photodecomposition and high toxicity. The present work is focused on the characterization of an inclusion complex of NFOH in 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD). The complexation with HP-beta-CD was investigated using reversed-phase liquid chromatography, solubility isotherms and nuclear magnetic resonance. The retention behavior was analyzed on a reversed-phase C-18 column, using acetonitrile-water (20/80, v/v) as the mobile phase, in which HP-beta-CD was incorporated as a mobile phase additive. The decrease in the retention times with increasing concentrations of HP-beta-CD enables the determination of the apparent stability constant of the complex (K = 6.2 +/- 0.3 M-1) by HPLC. The solubility isotherm was studied and the value for the apparent stability constant (K = 7.9 +/- 0.2 M-1) was calculated. The application of continuous variation method indicated the presence of a complex with 1:1 NFOH:HP-beta-CD stoichiometry. The photostability study showed that the formation of an inclusion complex had a destabilizing effect on the photodecomposition of NFOH when compared to that of the ""free"" molecule in solution. The mobility investigation (by NMR longitudinal relaxation time) gives information about the complexation of NFOH with HP-beta-CD. In preliminary toxicity studies, cell viability tests revealed that inclusion complexes were able to decrease the toxic effect (p < 0.01) caused by NFOH. (c) 2008 Elsevier B.V. All rights reserved.

Identificador

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, v.47, n.2, p.295-302, 2008

0731-7085

http://producao.usp.br/handle/BDPI/19717

10.1016/j.jpba.2008.01.010

http://dx.doi.org/10.1016/j.jpba.2008.01.010

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

Relação

Journal of Pharmaceutical and Biomedical Analysis

Direitos

restrictedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #hydroxymethylnitrofurazone #2-hydroxypropyl-beta-cyclodextrin #solubility isotherm #nuclear magnetic resonance #toxicity #BETA-CYCLODEXTRIN #INCLUSION COMPLEXES #PHARMACEUTICAL APPLICATIONS #LOCAL-ANESTHETICS #S(-) BUPIVACAINE #SOLUBILITY #STABILITY #H-1-NMR #NMR #PHOTOSTABILITY #Chemistry, Analytical #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion